I take from this that what’s reported were the best responses at any time on trial, according to Recist criteria. Ultimately all patients progress, my hunch is that those that left the trial is because they progressed and maybe gone onto other chemo, or maybe another clinical trial. The 3 remaining haven’t progressed yet.
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-12
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.46M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17307 | 6.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.7¢ | 1019 | 1 |
View Market Depth
| Last trade - 12.10pm 14/06/2024 (20 minute delay) ? |
| ATX (ASX) Chart |
Day chart unavailable